The Effects of Gamioryung-san Extracts on Streptozotocin-induced Diabetic Nephropathy Rats

가미오령산(加味五苓散)이 Streptozotocin으로 유발된 흰쥐의 당뇨병성(糖尿病性) 신증(腎症)에 미치는 영향

  • Lee, Yeon-Kyeong (Dept. of Oriental Internal Medicine, Graduate School of Daegu Haany University) ;
  • Kang, Seok-Bong (Dept. of Oriental Internal Medicine, Graduate School of Daegu Haany University)
  • 이연경 (대구한의대 한의과대학 신계내과학교실) ;
  • 강석봉 (대구한의대 한의과대학 신계내과학교실)
  • Published : 2012.12.30

Abstract

Objectives : The object of this study was to observe the effects of Gamioryung-san (GOS), which consists of 22 types of herbs, on streptozotocin (STZ)-induced diabetic nephropathy rats. Methods : Three different dosages of GOS were orally administered once a day for 28 days from 3 weeks after STZ treatment. Six groups, each of 8 rats per group were used. Changes on the body weights, blood glucose levels, serum BUN and creatinine levels, urine volumes, and UAER were observed with changes on the kidney malondialdehyde contents and glutathione, dismutase and catalase contents. In addition, histopathology of kidney, pancreas, thymus and spleen were observed. The results were compared with antioxidant silymarin 100 mg/kg, of which the effects on STZ -induced diabetes and related complications are already confirmed. Results : As a result of treatment of GOS 800, 400 or 200 mg/kg for 28 days, STZ-induced decreases of body weights, hyperglycemia, atrophic changes of pancreatic islets with decreases of insulin-immunoreactive cells and decreases of glucagon -immunoreactive cells were inhibited dose-dependently. Increases in kidney weight, serum BUN and creatinine levels, urine volumes, UAER, vasodilated atrophic glomerulus and abnormal tubules were inhibited dose-dependently. Also increases of kidney MDA contents and decreases of GSH contents, SOD and CAT activities, decreases of thymus and spleen weights, and atrophic changes at histopathological observation were also inhibited. The effects of GOS 400 mg/kg showed similar effects to silymarin 100 mg/kg. Conclusions : These results suggest that 400 mg/kg of GOS retarded the STZ-induced diabetic nephropathies as similarly to silymarin 100 mg/kg, through modulations of oxidative stress and immune systems.

Keywords

References

  1. 박정탁, 강식욱. 당뇨병성 신증의 병태생리. 대한내과학회지 2009;77(6):670-7.
  2. 전국 한의과대학 신계내과학교실. 신계내과학. 서울: 군자출판사; 2011, p. 95, 310-2.
  3. Fujii H, Kono K, Nakai K, Goto S, Komaba H, Hamada Y, et al. Oxidative and nitrosative stress and progression of diabetic nephropathy in type 2 diabetes. Am J Nephrol 2010;31:342-5. https://doi.org/10.1159/000297290
  4. Briede J, Stivrina M, Stoldere D, Vigante B, Duburs G. Effect of cerebrocrast on body and organ weight, food and water intake, and urine output of normal rats. Cell Biochem Funct 2008;26:908-15. https://doi.org/10.1002/cbf.1525
  5. Ceriello A, Quatraro A, Giugliano D. New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med 1992;9 :297-9. https://doi.org/10.1111/j.1464-5491.1992.tb01783.x
  6. Bolling BW, Chen CY, Blumberg JB. Tea and health: preventive and therapeutic usefulness in the elderly. Curr Opin Clin Nutr Metab Care 2009;12:42-8. https://doi.org/10.1097/MCO.0b013e32831b9c48
  7. Vessal G, Akmali M, Najafi P, Moein MR, Sagheb MM. Silymarin and milk thistle extract may prevent the progression of diabetic nephropathy in streptozotocin-induced diabetic rats. Ren Fail 2010;32:733-9. https://doi.org/10.3109/0886022X.2010.486488
  8. Kavutcu M, Canbolat O, Oztrk S, Olcay E, Ulutepe S, Ekinci C, et al. Reduced enzymatic antioxidant defense mechanism in kidney tissues from gentamicin-treated guinea pigs: effects of vitamins E and C. Nephron 1996;72:269-74. https://doi.org/10.1159/000188853
  9. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
  10. Draper HH, Hadley M. Methods in Enzymology. New York: Academic Press; 1990, p. 421.
  11. Eyer P, Podhradsk D. Evaluation of the micromethod for determination of glutathione using enzymatic cycling and Ellman's reagent. Anal Biochem 1986;153:57-6. https://doi.org/10.1016/0003-2697(86)90061-8
  12. Beauchamp C, Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971;44:276-8. https://doi.org/10.1016/0003-2697(71)90370-8
  13. Sternberger LA. The unlabeled antibody peroxidase -antiperoxidase (PAP) method. In: Sternberger LA, ed. Immunocytochemistry. New York: John Wiley & Sons; 1979, p. 104-6.
  14. Kim JD, Kang SM, Park MY, Jung TY, Choi HY, Ku SK. Ameliorative anti-diabetic activity of dangnyosoko, a Chinese herbal medicine, in diabetic rats. Biosci Biotechnol Biochem 2007; 71:1527-3. https://doi.org/10.1271/bbb.70058
  15. 장태수, 정해철, 류봉하. 증상을 중심으로 본 消渴과 糖尿病의 관계. 대한한방내과학회지 1985;2 :61-9.
  16. 杜鎬京. 東醫腎系學. 서울: 성보사; 2003, p. 514-7.
  17. Osicka TM, Yu Y, Panagiotopoulos S, Clavant SP, Kiriazis Z, Pike RN, et al. Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C. Diabetes 2000;49:87-9. https://doi.org/10.2337/diabetes.49.1.87
  18. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996;19:257-6. https://doi.org/10.2337/diacare.19.3.257
  19. Quine SD, Raghu PS. Effects of (-)-epicatechin, a flavonoid on lipid peroxidation and antioxidants in streptozotocin-induced diabetic liver, kidney and heart. Pharmacol Rep 2005;57:610-5.
  20. Anjaneyulu M, Chopra K. Diltiazem attenuates oxidative stress in diabetic rats. Ren Fail 2005;27:335-4. https://doi.org/10.1081/JDI-56630
  21. Wellington K, Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. Bio Drugs 2001;15:465-89.
  22. Huseini HF, Larijani B, Heshmat R, Fakhrzadeh H, Radjabipour B, Toliat T, et al. The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res 2006;20:1036-9. https://doi.org/10.1002/ptr.1988
  23. 김영석, 이병철, 안세영, 두호경, 안영민. 丹蔘이 당뇨병성 신병증 Rat의 신기능 및 조직학적 변화에 미치는 영향. 대한한방내과학회지 2008; 29(3):787-99.
  24. 홍광해, 이권호, 정기훈, 김용성, 이현주. 石膏가 streptozotocin으로 유발된 rat의 糖尿病性 腎症에 미치는 影響. 대한한방내과학회지 2008;29(4) :1025-36.
  25. 서수환, 김용성, 한양희. 水蛭이 Streptozotocin 으로 유발된 Rat의 糖尿病性 腎症에 미치는 影響. 대한한의학회지 2008;29(4):133-45.
  26. 조수인, 김형우, 김정상. 薏苡仁 추출물의 경구 투여가 Streptozotocin에 의한 흰쥐의 당뇨병성 신증에 미치는 영향. 대한본초학회지 2006;21(3) :75-81.
  27. 윤관희, 김용성. 蔘芪地黃湯加淫羊藿이 Streptozotocin으로 유발된 흰쥐의 糖尿病性 腎症에 미치는 영향. 대한한의학회지 2006;27(1):47-56.
  28. 조현주, 김용성. 蔘芪地黃湯加丹蔘, 大黃, 紅花가 Streptozotocin으로 유발된 생쥐의 糖尿病性腎症에 미치는 영향. 대한한방내과학회지 2005; 26(4):767-75.
  29. 신현권, 류충열. 韓藥複合處方이 Streptozotocin 으로 유발된 糖尿病 흰쥐의 혈당 및 糖尿病性腎症발현에 미치는 영향. 대한침구학회지 2008; 25(3):115-2.
  30. 나건호, 조수인, 조명래. 糖尿1號方의 藥鍼 및 口腔投與가 Streptozotocin에 의한 흰쥐의 糖尿病性 腎症에 미치는 영향. 대한침구학회지 2005; 22(5):1-10.
  31. 한방약리학교재편찬위원회 저. 한방약리학. 서울: 신일상사; 2010, p. 126-30, 315-21, 519-22, 746-9, 751-5, 769-73, 790-6.
  32. Pinzone Fox, ML, Sastry MK, Parenti DM, Simon, GL. Plasma leptin concentration increases early during highly active antiretroviral therapy for acquired immunodeficiency syndrome, independent of body weight. J Endocrinol Invest 2005;28 :1-3. https://doi.org/10.1007/BF03345520
  33. Montilla P, Barcos M, Munoz MC, Bujalance I, Munoz-Castaneda JR, Tunez I. Red wine prevents brain oxidative stress and nephropathy in streptozotocin-induced diabetic rats. J Biochem Mol Biol 2005;38:539-44. https://doi.org/10.5483/BMBRep.2005.38.5.539
  34. Sodikoff CH. Laboratory profiles of small animal diseases. A guide to laboratory diagnosis. 2nd ed. St. Louise: Mosby; 1995, p. 1-36.